Bhuvaneswari Krishnamoorthy1, William R Critchley2, Alexander J Thompson2, Katherine Payne2, Julie Morris2, Rajamiyer V Venkateswaran2, Ann L Caress2, James E Fildes2, Nizar Yonan2. 1. From Departments of Cardiothoracic Surgery (B.K., R.V.V., N.Y.) and Medical Statistics (J.M.), University Hospital of South Manchester NHS Foundation Trust, United Kingdom; Manchester Collaborative Centre for Inflammation Research, Faculty of Biology, Medicine and Health (W.R.C., B.K.), Manchester Collaborative Centre for Inflammation Research, Faculty of Biology, Medicine and Health (J.E.F.), Manchester Centre for Health Economics (A.J.T., K.P.), and School of Nursing and Midwifery (A.L.C.), University of Manchester, United Kingdom; and Faculty of Health and Social Care, Edge Hill University, Ormskirk, Lancashire, United Kingdom(B.K.). bhuvaneswari.bibleraaj@uhsm.nhs.uk. 2. From Departments of Cardiothoracic Surgery (B.K., R.V.V., N.Y.) and Medical Statistics (J.M.), University Hospital of South Manchester NHS Foundation Trust, United Kingdom; Manchester Collaborative Centre for Inflammation Research, Faculty of Biology, Medicine and Health (W.R.C., B.K.), Manchester Collaborative Centre for Inflammation Research, Faculty of Biology, Medicine and Health (J.E.F.), Manchester Centre for Health Economics (A.J.T., K.P.), and School of Nursing and Midwifery (A.L.C.), University of Manchester, United Kingdom; and Faculty of Health and Social Care, Edge Hill University, Ormskirk, Lancashire, United Kingdom(B.K.).
Abstract
BACKGROUND: Current consensus statements maintain that endoscopic vein harvesting (EVH) should be standard care in coronary artery bypass graft surgery, but vein quality and clinical outcomes have been questioned. The VICO trial (Vein Integrity and Clinical Outcomes) was designed to assess the impact of different vein harvesting methods on vessel damage and whether this contributes to clinical outcomes after coronary artery bypass grafting. METHODS: In this single-center, randomized clinical trial, patients undergoing coronary artery bypass grafting with an internal mammary artery and with 1 to 4 vein grafts were recruited. All veins were harvested by a single experienced practitioner. We randomly allocated 300 patients into closed tunnel CO2 EVH (n=100), open tunnel CO2 EVH (n=100), and traditional open vein harvesting (n=100) groups. The primary end point was endothelial integrity and muscular damage of the harvested vein. Secondary end points included clinical outcomes (major adverse cardiac events), use of healthcare resources, and impact on health status (quality-adjusted life-years). RESULTS: The open vein harvesting group demonstrated marginally better endothelial integrity in random samples (85% versus 88% versus 93% for closed tunnel EVH, open tunnel EVH, and open vein harvesting; P<0.001). Closed tunnel EVH displayed the lowest longitudinal hypertrophy (1% versus 13.5% versus 3%; P=0.001). However, no differences in endothelial stretching were observed between groups (37% versus 37% versus 31%; P=0.62). Secondary clinical outcomes demonstrated no significant differences in composite major adverse cardiac event scores at each time point up to 48 months. The quality-adjusted life-year gain per patient was 0.11 (P<0.001) for closed tunnel EVH and 0.07 (P=0.003) for open tunnel EVH compared with open vein harvesting. The likelihood of being cost-effective, at a predefined threshold of £20 000 per quality-adjusted life-year gained, was 75% for closed tunnel EVH, 19% for open tunnel EVH, and 6% for open vein harvesting. CONCLUSIONS: Our study demonstrates that harvesting techniques affect the integrity of different vein layers, albeit only slightly. Secondary outcomes suggest that histological findings do not directly contribute to major adverse cardiac event outcomes. Gains in health status were observed, and cost-effectiveness was better with closed tunnel EVH. High-level experience with endoscopic harvesting performed by a dedicated specialist practitioner gives optimal results comparable to those of open vein harvesting. CLINICAL TRIAL REGISTRATION: URL: https://www.isrctn.com. International Standard Randomised Controlled Trial Registry Number: 91485426.
BACKGROUND: Current consensus statements maintain that endoscopic vein harvesting (EVH) should be standard care in coronary artery bypass graft surgery, but vein quality and clinical outcomes have been questioned. The VICO trial (Vein Integrity and Clinical Outcomes) was designed to assess the impact of different vein harvesting methods on vessel damage and whether this contributes to clinical outcomes after coronary artery bypass grafting. METHODS: In this single-center, randomized clinical trial, patients undergoing coronary artery bypass grafting with an internal mammary artery and with 1 to 4 vein grafts were recruited. All veins were harvested by a single experienced practitioner. We randomly allocated 300 patients into closed tunnel CO2 EVH (n=100), open tunnel CO2 EVH (n=100), and traditional open vein harvesting (n=100) groups. The primary end point was endothelial integrity and muscular damage of the harvested vein. Secondary end points included clinical outcomes (major adverse cardiac events), use of healthcare resources, and impact on health status (quality-adjusted life-years). RESULTS: The open vein harvesting group demonstrated marginally better endothelial integrity in random samples (85% versus 88% versus 93% for closed tunnel EVH, open tunnel EVH, and open vein harvesting; P<0.001). Closed tunnel EVH displayed the lowest longitudinal hypertrophy (1% versus 13.5% versus 3%; P=0.001). However, no differences in endothelial stretching were observed between groups (37% versus 37% versus 31%; P=0.62). Secondary clinical outcomes demonstrated no significant differences in composite major adverse cardiac event scores at each time point up to 48 months. The quality-adjusted life-year gain per patient was 0.11 (P<0.001) for closed tunnel EVH and 0.07 (P=0.003) for open tunnel EVH compared with open vein harvesting. The likelihood of being cost-effective, at a predefined threshold of £20 000 per quality-adjusted life-year gained, was 75% for closed tunnel EVH, 19% for open tunnel EVH, and 6% for open vein harvesting. CONCLUSIONS: Our study demonstrates that harvesting techniques affect the integrity of different vein layers, albeit only slightly. Secondary outcomes suggest that histological findings do not directly contribute to major adverse cardiac event outcomes. Gains in health status were observed, and cost-effectiveness was better with closed tunnel EVH. High-level experience with endoscopic harvesting performed by a dedicated specialist practitioner gives optimal results comparable to those of open vein harvesting. CLINICAL TRIAL REGISTRATION: URL: https://www.isrctn.com. International Standard Randomised Controlled Trial Registry Number: 91485426.
Authors: Keith Allen; Davy Cheng; William Cohn; Mark Connolly; James Edgerton; Volkmar Falk; Janet Martin; Toshiya Ohtsuka; Richard Vitali Journal: Innovations (Phila) Date: 2005
Authors: Joseph F Sabik; Eugene H Blackstone; A Marc Gillinov; Nicholas G Smedira; Bruce W Lytle Journal: Circulation Date: 2006-07-04 Impact factor: 29.690
Authors: Bhuvaneswari Krishnamoorthy; William R Critchley; Alex T Glover; Janesh Nair; Mark T Jones; Paul D Waterworth; James E Fildes; Nizar Yonan Journal: Interact Cardiovasc Thorac Surg Date: 2012-05-18
Authors: Syed Faisal Hashmi; Bhuvaneswari Krishnamoorthy; William R Critchley; Peter Walker; Paul W Bishop; Rajamiyer V Venkateswaran; James E Fildes; Nizar Yonan Journal: Interact Cardiovasc Thorac Surg Date: 2014-10-29
Authors: Emile N Brown; Zachary N Kon; Richard Tran; Nicholas S Burris; Junyen Gu; Patrick Laird; Philip S Brazio; Seeta Kallam; Kimberly Schwartz; Lisa Bechtel; Ashish Joshi; Shaosong Zhang; Robert S Poston Journal: J Thorac Cardiovasc Surg Date: 2007-09-29 Impact factor: 5.209
Authors: Bhuvaneswari Krishnamoorthy; Joesph Zacharias; William R Critchley; Melissa Rochon; Iryna Stalpinskaya; Azita Rajai; Rajamiyer V Venkateswaran; Shahzad G Raja; Toufan Bahrami Journal: NIHR Open Res Date: 2021-07-08
Authors: Etem Caliskan; Domingos Ramos de Souza; Andreas Böning; Oliver J Liakopoulos; Yeong-Hoon Choi; John Pepper; C Michael Gibson; Louis P Perrault; Randall K Wolf; Ki-Bong Kim; Maximilian Y Emmert Journal: Nat Rev Cardiol Date: 2019-08-27 Impact factor: 32.419